Currently, 75% of cancer patients will not respond to a particular drug in a class of agents. Highly personalized genomic insights can help determine an effective course of action.
An estimated 70% of cancer care in the United States is provided by oncologists in community hospitals. These providers are responsible for patients with a variety of cancers and often do not have access to specialized genomic information and testing for each patient.
Additionally, with hundreds of thousands of medical studies being published yearly, it is impossible for these doctors to stay on top of the latest medical literature and clinical trials.
Working with Watson Genomics from Quest Diagnostics, oncologists can better identify personalized therapeutic options for their patients. The treating oncologist sends a patient’s tumor biopsy to Quest Diagnostics, where medical specialists or pathologists use next-generation sequencing, combined with Watson’s clinical interpretation, to analyze the tumor DNA.
Watson uses its cognitive computing capabilities to extract relevant information from millions of pages of medical literature and clinical trials to help identify therapies associated with the patient’s tumor. A Quest pathologist reviews and validates the findings, and prepares a report that the treating oncologist can use to create a personalized treatment plan tailored to the patient’s unique tumor.
Cancer mutations display wide variances. With 160,000 cancer studies released each year, correlation of mutations with cancer and specific treatments requires access to medical literature knowledge bases that are routinely updated with rapidly-evolving discoveries. With Watson Genomics from Quest Diagnostics, specialists are able to work with more relevant information.
More personalized care inspires more hope
With the ability to access and analyze relevant information, Quest Diagnostics is helping oncologists identify personalized therapeutic options that match patients’ targeted tumor mutations.
How oncologists and patients are working with Watson Genomics from Quest Diagnostics
1. The patient sees an oncologist who performs a biopsy.
2. A biopsy of the tumor is sent to Quest Diagnostics for genomic sequencing of the tumor’s DNA.
3. After sequencing the tumor DNA, Quest sends the genetic data output to IBM’s Watson for Genomics.
4. Watson extracts relevant information from millions of pages of medical literature and clinical trials
5. An evidence-based report is generated listing the DNA alterations related to the patient’s tumor and potential therapeutic options that match a patient’s tumor mutations.
Clinicians, businesses, educators, and governments are working with Watson. In 45 countries and 20 industries, Watson is helping people make sense of data to help them make informed decisions while uncovering new ideas.
How can we help you?
How does Watson work?
For Developers & IT
Build innovative cognitive apps with Watson on IBM Cloud:
Watson products and apps can help illuminate insights and bring the power of cognitive computing to your organization.
Share this story: